NCT04445025View on ClinicalTrials.gov

Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 30, 2024

Study Completion Date

December 30, 2024

Conditions
InfertilityEndometriosis
Interventions
DRUG

Elagolix 200 MG

Elagolix 200mg twice daily orally for 60 days prior to beginning frozen embryo transfer preparation

DRUG

Leuprolide Acetate 3.75 MG/ML

Leuprolide Acetate intramuscularly every 28 days (twice) prior to beginning frozen embryo transfer preparation

DIAGNOSTIC_TEST

Lab work

Serum follicle stimulating hormone (FSH), estradiol, luteinizing hormone (LH), progesterone, human chorionic gonadotropin (hCG), serum for microarray analysis, complete blood count, and chemistry panel with liver functions levels will be drawn via blood draw

Trial Locations (1)

80124

Colorado Center for Reproductive Medicine, Lone Tree

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Colorado Center for Reproductive Medicine

OTHER